Challenges in the evaluation of emerging highly specialised technologies: Is there a role for living HTA?
There is currently deep uncertainty about the clinical benefits and cost effectiveness of
highly specialised technologies (HSTs), like gene and cell therapies. These treatments are …
highly specialised technologies (HSTs), like gene and cell therapies. These treatments are …
Advanced Therapy Medicinal Products
V Neuhaus, D Schaudien, S Dehmel - Drug Discovery and Evaluation …, 2023 - Springer
In recent years advances in biology, biotechnology, and medical research have led to a new
category of biologicals–the advanced therapy medicinal products (ATMPs). ATMPs open up …
category of biologicals–the advanced therapy medicinal products (ATMPs). ATMPs open up …
[PDF][PDF] A splice of the pie–Where are we with our genetic interventions?
A Shah, DNP Joseph - mm2022.shpa.org.au
Adnan Shah 1 Deshina Naidoo2 Pathma Joseph1, 2 Page 1 A splice of the pie – Where are
we with our genetic interventions? Adnan Shah 1 Deshina Naidoo2 Pathma Joseph1, 2 1 …
we with our genetic interventions? Adnan Shah 1 Deshina Naidoo2 Pathma Joseph1, 2 1 …